HESI RN
Reproductive Health Exam Questions And Answers
1. During the menstrual cycle, which hormone maintains the corpus luteum?
- A. Luteinizing hormone
- B. Follicle-stimulating hormone
- C. Progesterone
- D. Relaxin
Correct answer: A
Rationale: During the menstrual cycle, luteinizing hormone maintains the corpus luteum. The correct answer is A. Luteinizing hormone stimulates the corpus luteum to produce progesterone. Choice B, Follicle-stimulating hormone, is involved in stimulating the growth of follicles in the ovaries. Choice C, Progesterone, is produced by the corpus luteum and plays a role in preparing the endometrium for implantation. Choice D, Relaxin, is involved in processes such as softening the cervix and ligaments during pregnancy, but it is not responsible for maintaining the corpus luteum.
2. Which component of reproductive health ensures the provision of quality reproductive health services at all levels of the health care system?
- A. Safe motherhood
- B. Adolescent health and development
- C. Health service delivery
- D. Reproductive health information
Correct answer: C
Rationale: Health service delivery is the component of reproductive health that specifically focuses on ensuring the provision of quality reproductive health services at all levels of the healthcare system. While safe motherhood and adolescent health are important aspects of reproductive health, they do not directly address the quality of health services delivery. Reproductive health information, although crucial, is not the component responsible for ensuring the quality of services provided.
3. What is Carboprost used for?
- A. Affects milk production.
- B. Relieve constriction ring.
- C. Management of post-partum haemorrhage.
- D. Induce labor.
Correct answer: C
Rationale: Carboprost is used in the management of post-partum haemorrhage. This medication helps to reduce excessive bleeding after childbirth. Choices A, B, and D are incorrect. Carboprost does not affect milk production, relieve constriction ring, or induce labor.
4. Discuss the anatomical/physiological changes in pregnancy under the following: Kidney/renal system
- A. Kidneys increase in size, pelvis dilates, ureters elongate and dilate, and the glomerular filtration rate increases.
- B. Kidneys decrease in size, and glomerular filtration rate decreases.
- C. There is no change in kidney size or ureter function, but the glomerular filtration rate decreases.
- D. Kidneys shrink, and ureters remain the same.
Correct answer: A
Rationale: During pregnancy, the kidneys increase in size, the pelvis dilates, ureters elongate and dilate, and the glomerular filtration rate increases. This is due to the increased metabolic demands and hormonal changes during pregnancy. Choice B is incorrect as the kidneys do not decrease in size, and the glomerular filtration rate actually increases. Choice C is incorrect as there are changes in kidney size and ureter function during pregnancy. Choice D is incorrect as the kidneys do not shrink during pregnancy.
5. What is Dinoprostone commonly used for?
- A. Cervical priming.
- B. Pain management during labor.
- C. Management of pre-term labor.
- D. Management of post-partum hemorrhage.
Correct answer: C
Rationale: Dinoprostone is commonly used for the management of pre-term labor. While it can be used for cervical priming, its primary indication is for pre-term labor. Choice A is partially correct but not the most common use of Dinoprostone. Choices B and D are incorrect as Dinoprostone is not primarily used for pain management during labor or for the management of post-partum hemorrhage.
Similar Questions
Access More Features
HESI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access